{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,21]],"date-time":"2026-02-21T11:55:49Z","timestamp":1771674949046,"version":"3.50.1"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2020,3,1]],"date-time":"2020-03-01T00:00:00Z","timestamp":1583020800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,1,29]],"date-time":"2020-01-29T00:00:00Z","timestamp":1580256000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Saudi Pharmaceutical Journal"],"published-print":{"date-parts":[[2020,3]]},"DOI":"10.1016\/j.jsps.2020.01.019","type":"journal-article","created":{"date-parts":[[2020,2,10]],"date-time":"2020-02-10T16:46:03Z","timestamp":1581353163000},"page":"374-379","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"title":["Prevalence and associated risk factors of acne relapse among Saudi acne vulgaris patients using isotretinoin"],"prefix":"10.1007","volume":"28","author":[{"given":"Alshammari","family":"SA","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alamri","family":"Y","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alanazi","family":"AM","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Almuhanna","family":"SA","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pinjabi","family":"L","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alsnaidi","family":"NA","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"10.1016\/j.jsps.2020.01.019_b0005","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/bjd.13462","article-title":"A global perspective on the epidemiology of acne","volume":"172","author":"Tan","year":"2015","journal-title":"Br. J. Dermatol."},{"issue":"01","key":"10.1016\/j.jsps.2020.01.019_b0010","doi-asserted-by":"crossref","first-page":"29","DOI":"10.22442\/jlumhs.181710545","article-title":"Cardiff acne disability index based quality of life in acne patients, risk factors and associations","volume":"17","author":"Shams","year":"2018","journal-title":"J. Liaquat Univ. Med. Health Sci."},{"issue":"2","key":"10.1016\/j.jsps.2020.01.019_b0015","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1111\/jdv.14475","article-title":"Acne prevalence and associations with lifestyle: a cross-sectional online survey of adolescents\/young adults in 7 European countries","volume":"32","author":"Wolkenstein","year":"2018","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"issue":"1","key":"10.1016\/j.jsps.2020.01.019_b0020","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1590\/abd1806-4841.20198203","article-title":"Rocha MADd. Adult female acne: a guide to clinical practice","volume":"94","author":"Bagatin","year":"2019","journal-title":"Anais Brasil. Dermatol."},{"issue":"1","key":"10.1016\/j.jsps.2020.01.019_b0025","doi-asserted-by":"crossref","first-page":"1","DOI":"10.5455\/2349-3933.ijam20150201","article-title":"Acne vulgaris management: what\u2019s new and what\u2019s still true","volume":"2","author":"Seth","year":"2015","journal-title":"Int. J. Adv. Med."},{"key":"10.1016\/j.jsps.2020.01.019_b0030","doi-asserted-by":"crossref","unstructured":"Zaenglein AL, Pathy AL, Schlosser BJ, Alikhan A, Baldwin HE, Berson DS, et al. Guidelines of care for the management of acne vulgaris. J. Am. Acad. Dermatol. 2016;74(5):945-73. e33.","DOI":"10.1016\/j.jaad.2015.12.037"},{"issue":"4","key":"10.1016\/j.jsps.2020.01.019_b0035","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1067\/mjd.2002.120529","article-title":"Use of isotretinoin (Accutane) in the United States: rapid increase from 1992 through 2000","volume":"46","author":"Wysowski","year":"2002","journal-title":"J. Am. Acad. Dermatol."},{"issue":"2","key":"10.1016\/j.jsps.2020.01.019_b0040","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1159\/000090646","article-title":"The truth behind this undeniable efficacy\u2013recurrence rates and relapse risk factors of acne treatment with oral isotretinoin","volume":"212","author":"Zouboulis","year":"2006","journal-title":"Dermatology"},{"issue":"1","key":"10.1016\/j.jsps.2020.01.019_b0045","first-page":"61","article-title":"Acne relapse rate and predictors of relapse following treatment with oral isotretinoin","volume":"104","author":"Morales-Cardona","year":"2013","journal-title":"Actas Dermo-Sifiliogr\u00e1ficas (Engl. Ed.)"},{"issue":"2","key":"10.1016\/j.jsps.2020.01.019_b0050","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1159\/000090658","article-title":"Prospective study of risk factors of relapse after treatment of acne with oral isotretinoin","volume":"212","author":"Quereux","year":"2006","journal-title":"Dermatology"},{"issue":"6","key":"10.1016\/j.jsps.2020.01.019_b0055","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1111\/j.1365-2133.2007.08250.x","article-title":"Isotretinoin therapy and the incidence of acne relapse: a nested case\u2013control study","volume":"157","author":"Azoulay","year":"2007","journal-title":"Br. J. Dermatol."},{"issue":"12","key":"10.1016\/j.jsps.2020.01.019_b0060","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1001\/jamadermatol.2013.6746","article-title":"High-dose isotretinoin treatment and the rate of retrial, relapse, and adverse effects in patients with acne vulgaris","volume":"149","author":"Blasiak","year":"2013","journal-title":"JAMA Dermatol."},{"issue":"1","key":"10.1016\/j.jsps.2020.01.019_b0065","first-page":"3","article-title":"Women's experiences regarding isotretinoin risk reduction counseling in Riyadh","volume":"23","author":"Algoblan","year":"2019","journal-title":"J. Dermatol. Dermatol. Surgery"},{"key":"10.1016\/j.jsps.2020.01.019_b0070","unstructured":"Dreno B, Bordet C, Seite S, Taieb C, Acn\u00e9\u2019Dermatologists R. Acne relapses: impact on quality of life and productivity. J. Europ. Acad. Dermatol. Venereol. 2019;33(5):937-943."},{"issue":"1","key":"10.1016\/j.jsps.2020.01.019_b0075","doi-asserted-by":"crossref","first-page":"40","DOI":"10.5958\/0974-360X.2019.00008.8","article-title":"A survey on the most common side effects of isotretinoin among a group of syrian patients","volume":"12","author":"Harfouch","year":"2019","journal-title":"Res. J. Pharm. Technol."},{"issue":"2","key":"10.1016\/j.jsps.2020.01.019_b0080","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.jdds.2017.01.001","article-title":"Prevalence, level of knowledge and lifestyle association with acne vulgaris among medical students","volume":"21","author":"Alajlan","year":"2017","journal-title":"J. Dermatol. Dermatol. Surg."},{"issue":"1","key":"10.1016\/j.jsps.2020.01.019_b0085","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1111\/bjd.15668","article-title":"Efficacy and adverse events of oral isotretinoin for acne: a systematic review","volume":"178","author":"Vallerand","year":"2018","journal-title":"Br. J. Dermatol."},{"key":"10.1016\/j.jsps.2020.01.019_b0090","doi-asserted-by":"crossref","first-page":"153","DOI":"10.2147\/PPA.S149355","article-title":"Assessment of medication adherence and responsible use of isotretinoin and contraception through Belgian community pharmacies by using pharmacy refill data","volume":"12","author":"Biset","year":"2018","journal-title":"Pat. Prefer. Adher."},{"issue":"1","key":"10.1016\/j.jsps.2020.01.019_b0095","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2018-021549","article-title":"Use of isotretinoin and risk of depression in patients with acne: a systematic review and meta-analysis","volume":"9","author":"Li","year":"2019","journal-title":"BMJ Open."},{"issue":"2","key":"10.1016\/j.jsps.2020.01.019_b0100","first-page":"86","article-title":"Correlation between family history and the age of onset of childhood acne in relation to sex and type of acne. Acta dermatovenerologica","volume":"27","author":"\u0160ijak","year":"2019","journal-title":"Croatica."},{"issue":"2","key":"10.1016\/j.jsps.2020.01.019_b0105","first-page":"81","article-title":"High body mass index is a risk factor for acne severity in adolescents: a preliminary report","volume":"27","author":"Lech","year":"2019","journal-title":"Acta Dermatovenerol. Croatica."},{"issue":"2","key":"10.1016\/j.jsps.2020.01.019_b0110","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.ijwd.2017.10.006","article-title":"A review of diagnosis and treatment of acne in adult female patients","volume":"4","author":"Tan","year":"2018","journal-title":"Int. J. Women's Dermatol."},{"issue":"1","key":"10.1016\/j.jsps.2020.01.019_b0115","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1001\/jamadermatol.2015.3091","article-title":"Laboratory monitoring during isotretinoin therapy for acne: a systematic review and meta-analysis","volume":"152","author":"Lee","year":"2016","journal-title":"JAMA Dermatol."},{"issue":"6","key":"10.1016\/j.jsps.2020.01.019_b0120","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1111\/j.1365-2133.2010.09836.x","article-title":"Advice on the safe introduction and continued use of isotretinoin in acne in the UK 2010","volume":"162","author":"Goodfield","year":"2010","journal-title":"Br. J. Dermatol."},{"issue":"1","key":"10.1016\/j.jsps.2020.01.019_b0125","doi-asserted-by":"crossref","first-page":"63","DOI":"10.3109\/01480545.2014.905590","article-title":"Oral isotretinoin therapy of acne patients decreases serum paraoxonase-1 activity through increasing oxidative stress","volume":"38","author":"Ozkol","year":"2015","journal-title":"Drug Chem. Toxicol."}],"container-title":["Saudi Pharmaceutical Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1319016420300293?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1319016420300293?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,6]],"date-time":"2025-01-06T17:24:16Z","timestamp":1736184256000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1319016420300293"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3]]},"references-count":25,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2020,3]]}},"alternative-id":["S1319016420300293"],"URL":"https:\/\/doi.org\/10.1016\/j.jsps.2020.01.019","relation":{},"ISSN":["1319-0164"],"issn-type":[{"value":"1319-0164","type":"print"}],"subject":[],"published":{"date-parts":[[2020,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prevalence and associated risk factors of acne relapse among Saudi acne vulgaris patients using isotretinoin","name":"articletitle","label":"Article Title"},{"value":"Saudi Pharmaceutical Journal","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jsps.2020.01.019","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The Author(s). Published by Elsevier B.V. on behalf of King Saud University.","name":"copyright","label":"Copyright"}]}}